Ground-breaking digital approach helps cut pathology waiting times
An innovative partnership between East Kent Hospitals and digital pathology company Source LDPath, a part of SourceBio International plc, is helping to reduce pathology waiting times and improve patient care.
Retinal devices: how improved technical capability saved my sight
Head of Electronics Engineering at Team Consulting gives an account of how improved technical capability saved their sight.
Biocair develops dedicated team for cell and gene therapy logistics
Biocair has invested heavily in the creation of a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy sector.
6 methods for delivering drugs to the eye
The human eye is incredibly resilient. It has several physiological barriers to resist penetration of foreign molecules and particles, which makes drug delivery to the eye a real challenge.
FUJIFILM Irvine Scientific acquires exclusive license for artificial intelligence for IVF
Santa Ana, Calif., FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), announces it has exclusively licensed the intellectual property relating to artificial intelligence (AI) for image-based evaluation of human embryos to improve in-vitro fertilization (IVF) success rates
Collaborating, creating and innovating with Guardtech’s revamped Design team
New Design Manager David Scholes reveals what the future holds for Suffolk firm’s freshly bolstered department.
Marion Jongkind joins Salus Wellness Clinics
We are very pleased to announce that Marion Jongkind has joined Salus Wellness this month.
Richard Withers joins Cambridge Healthcare Research as Strategic Advisor
The Board of Directors at Cambridge Healthcare Research (CHR) appoints Richard Withers as Strategic Advisor to support the business through it’s next period of growth.
Andrew Bell appointed Centre Manager at the EpiCentre, Haverhill
Andrew Bell has been appointed the new Centre Manager at the EpiCentre in Haverhill succeeding Kelly Boosey, and is excited to start his new role in the latter part of June.
Optibrium receives further investment from Kester Capital
Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.
Entries now open for the 2022 Deloitte UK Technology Fast 50 awards
Now in its 25th year, the awards recognise and rank the 50 fastest growing technology companies in the UK; Last year’s winner ClearBank achieved a three-year growth rate of 21,569% to the year 2020/21; The average three-year growth rate recorded for companies in the Deloitte UK Technology Fast 50 was 3,337% in 2020/21; Last year’s Fast 50 companies generated combined revenues of £2.92…
Nuffield Health - let’s talk glue ear in children
As the only private hospital in the area that can see children of all ages, from little ones to under-18s, Nuffield Health Cambridge Hospital presents a free virtual event for anyone who would like to know more about glue ear in children.
Yourgene Health Launches LightBench Detect for Fetal Fraction Enrichment
Manchester, UK - Yourgene Health plc, a leading international molecular diagnostics group, announces the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy (ISPD).
Early diagnosis of Cancer - myth or reality?
Early diagnosis of cancer - myth or reality?
‘Keep your cool’ – advice for men wanting to be fathers
There are many ways to improve sperm health, advises specialist in male fertility ahead of Father’s Day .
The elephant in the room: addressing device development challenges early on
Andrea Pybus says: I’ve often heard colleagues say that it would be the ‘challenge we didn’t anticipate, that catches us out’. I have certainly experienced this. But more often than not, the challenges or ‘project killers’ I have witnessed were identified early in the medical device programme. In this blog I discuss the reasons why unanswered questions asked at the start of a project can get…
Four steps to selecting the right device to deliver therapies
Charlotte Harris, Head of Front End Innovation at Team Consulting, discusses four steps that have to be taken when selecting the right drug delivery device for your chosen therapy.
See you in Vegas?
The Marcus Evans Medical Device Manufacturing and R&D Summit will be live in Las Vegas from the 23rd-24th of June and we can’t wait to see you there.
Arecor announces exclusive collaboration with a top 5 global pharmaceutical company
Cambridge, UK - Arecor Therapeutics plc, the biopharmaceutical group advancing today’s therapies to enable healthier lives, announces that it has signed an exclusive formulation study collaboration with a top five global pharmaceutical company.
Global Access Diagnostics (GADx) formed to expand affordable access to advanced rapid diagnostic technologies
Bedford, UK - Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, formally introduces its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests.
seqWell appoints Dr Amy Liao to Board of Directors
Beverly, Mass – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following…
Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer
Cambridge - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of superior and differentiated ADCs in the treatment of solid tumours where there is a high unmet need.
Tackling the challenges of cloud connectivity
In a new article for ONdrugDelivery, Gabrielle Whitworth-Smith and Thomas Watts consider the various challenges of building cloud connectivity into your medical device platform.
How digital UX in clinical trials can improve measures
Implementing Digital health technologies effectively can be challenging. In a new article for ONdrugDelivery, Ben Cox, Head of Digital Design, discusses how adopting a UX approach when designing digital tools can lead to more meaningful measures.
Evonetix appoints Colin McCracken as Chief Executive Officer
Cambridge, UK - EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, announces the appointment of Colin McCracken as Chief Executive Officer with immediate effect. Colin’s appointment will support the next phase of the Company’s development and the commercialisation of its semiconductor-based DNA synthesis platform.